Ranbaxy acquires rights for Ochoa Labs’ skincare products

22 May 2009

1
Speaking...

Ranbaxy Laboratories Ltd said late on Thursday that it has acquired trademarks, product dossiers and marketing rights from Ochoa Laboratories Ltd for its entire range of dermatological and lifestyle products.

However, it did not provide any financial details in its filing to the Bombay Stock Exchange.

Ranbaxy already has a presence in the dermatology market including steroids with products such as Zole-F, Suncros, Efflora, Fucidin and Teczine, it said in its statement. In India, the market in the dermatology segment is worth Rs1,950 crore a year, and it is growing rapidly at 11 per cent, according to the company.

The acquired brands command considerable equity with doctors and are market leaders in their respective categories, the Mohali, Punjab-based Ranbaxy said in its statement.

The products enjoy high margins because of their novelty and brand appeal, and will be initially marketed in India. They complement Ranbaxy's existing derma portfolio, it added.

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers